The Evidence for and Against Corticosteroid Prophylaxis in At-Risk Patients

Radiol Clin North Am. 2017 Mar;55(2):413-421. doi: 10.1016/j.rcl.2016.10.012.

Abstract

Corticosteroid prophylaxis is commonly used for the prevention of allergiclike reactions to iodinated and gadolinium-based contrast material in patients at highest risk of an allergiclike reaction. However, it has only a weak mitigating effect on allergiclike reactions, probably does not affect the severity of subsequent reactions, and does not prevent all reactions. Breakthrough reactions occur, are usually the same severity as the index reaction, and can occasionally be life threatening. Premedication of inpatients is likely associated with substantial cost and harm because of hospital length-of-stay prolongation; these indirect effects may exceed the benefits of premedication in this population.

Keywords: Allergiclike reaction; Anaphylaxis; Contrast material; Corticosteroid prophylaxis; Premedication; Pretreatment; Steroid preparation.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Contrast Media / adverse effects*
  • Drug Hypersensitivity / prevention & control*
  • Gadolinium / adverse effects
  • Humans
  • Iodine / adverse effects
  • Premedication / methods*
  • Risk Factors

Substances

  • Adrenal Cortex Hormones
  • Contrast Media
  • Iodine
  • Gadolinium